<?xml version="1.0" encoding="UTF-8"?>
<p id="Par72">One of the lessons of the COVID-19 pandemic, and a source of anxiety and worry, is that it seems impossible to predict who among the infected will suffer from rapid evolution to acute respiratory distress syndrome and multi-organ failure. This section describes clinical and laboratory biomarkers that may indicate a high risk of such a transition and are related to altered EAS functions.</p>
